Please Note
We brought you to this page based on your search query. If this isn't what you are looking for, you can continue to Search Results for ""
The maximum number of items you can export is 3,000. Please reduce your list by using the filtering tool to the left.
Close
Chystáte se opustit lokální stránky Czech Proto budete přesměrování na celosvětové stránky, které jsou dostupné?
Nezobrazujte znovu tuto zprávu
Ano
Ne

Vyhledávali jste podle

Hledali jste

Relevantní informace

Důležité kontakty

Připravované akce

Příbuzné produkty

Farmaceutika, všeobecně a speciální - Pennsylvania

Nejdůležitější body

Výzkum a studie
Organizace
Upřesněte, prosím, svou studii podle segmentu trhu, aby bylo možno získat odpovídající ratingy a monitorované údaje.
  DatumTyp dokumentu Název Emitent/entita
28 Mar 2024 Credit Opinion Cencora, Inc.: Update to credit analysis following outlook revision to positive Cencora, Inc.
27 Mar 2024 Rating Action Moody's affirms Cencora's Baa2 senior unsecured rating, outlook revised to positive AmeriSource Hea...
Bergen Brunswig...
Bergen Brunswig...
Bergen Capital ...
Bergen Capital ...
Bergen Capital ...
Cencora, Inc.
Durr-Fillauer M...
PharMerica, Inc...
19 Mar 2024 Rating Action Moody's affirms GSK's A2 ratings; outlook remains stable GlaxoSmithKline...
GlaxoSmithKline...
GlaxoSmithKline...
GlaxoSmithKline...
GSK Capital B.V...
GSK Capital K.K...
GSK plc
13 Mar 2024 Peer Snapshot Cencora, Inc. - December 2023 (LTM): Peer Snapshot Cencora, Inc.
05 Feb 2024 Rating Action Moody's assigns Baa2 rating to Cencora's new senior notes Cencora, Inc.
22 Dec 2023 Peer Snapshot Cencora - September 2023 (LTM): Peer Snapshot Cencora, Inc.
17 Dec 2023 Rating Action Moody's affirms Teva's Ba2 ratings; outlook stable Teva Pharmaceut...
Teva Pharmaceut...
TEVA PHARMACEUT...
TEVA PHARMACEUT...
Teva Pharmaceut...
Teva Pharmaceut...
14 Dec 2023 Announcement of Periodic Review Moody's announces completion of a periodic review for a group of Pharmaceutical issuers ADVANZ PHARMA H...
AI Sirona (Luxe...
Almirall, S.A.
AstraZeneca Fin...
AstraZeneca PLC
Cerebro HoldCo ...
Cheplapharm Arz...
Cidron Aida Fin...
Covis Finco S.a...
Covis Parent SC...
...
05 Oct 2023 Rating Action Moody's affirms Viatris' Baa3 rating; outlook remains stable Mylan Inc.
Mylan N.V.
Upjohn Finance ...
Viatris Inc.
29 Sep 2023 Announcement of Periodic Review Moody's announces completion of a periodic review for a group of Distribution and Supply Chain Services issuers AEC Parent Hold...
Allegiance Corp...
Avantor Funding...
Cardinal Health...
Cencora, Inc.
Covetrus, Inc.
Golden State Bu...
McKesson Corpor...
Owens & Minor, ...
Complete Your Profile
Please complete your profile before submitting your comments.
We're Sorry